EVER elusive, yet another drug that showed great promise for treatment of Alzheimer's Disease (AD) has failed in late phase studies.
Lundbeck's idalopirdine showed no benefits in Phase III clinical trials, published in JAMA - see jamanetwork.com for the study.
ADVANCED Pharmacy Australia (AdPha) has welcomed the WA Government’s $829 million boost to public hospital funding as part of the record $1.4 billion health investment in the 2025-26 WA Budget, but warned that infrastructure alone is not enough.
INTERNATIONAL research into the impacts of a first-of-its-kind GLP-1 pill were revealed this weekend in the New England Journal of Medicine and at the American Diabetes Association’s annual conference in Chicago.
SANDOZ has announced that it has entered into a distribution agreement with CSL Seqirus to distribute Benpen (benzylpenicillin sodium), a vital antibiotic used in the treatment of a broad range of serious bacterial infections.
Notifications
